Evaluation and Management of Elevated Alkaline Phosphatase and GGT

Introduction to Elevated Alkaline Phosphatase and GGT

• The most common causes of concurrent elevation of alkaline phosphatase (ALP) and GGT are cholestatic liver diseases, biliary obstruction, infiltrative liver diseases, sepsis, and alcohol consumption 1, 2, 3

Diagnostic Approach

• When both enzymes are elevated, it confirms a hepatobiliary origin of ALP, as GGT is not found in bone 1, 2
• The American Gastroenterological Association recommends that patients with elevated ALP and GGT undergo further evaluation to determine the cause 1, 2

Cholestatic Liver Diseases

• Primary biliary cholangitis (PBC) is diagnosed when there is an elevation of ALP (typically 2-10× upper limit of normal (ULN)) and positive antimitochondrial antibodies 1
• Primary sclerosing cholangitis (PSC) typically presents with ALP ≥1.5× ULN and is strongly associated with inflammatory bowel disease 1, 2

Biliary Obstruction

• Choledocholithiasis affects approximately 18% of adults undergoing cholecystectomy and significantly impacts liver tests 1, 2
• GGT has a sensitivity of 80.6% and specificity of 75.3% for detecting common bile duct stones in acute cholecystitis 3

Infiltrative Liver Diseases

• Metastatic liver disease is the most common cause of isolated elevated ALP 2
• Non-malignant infiltrative diseases include amyloidosis and sarcoidosis 1, 2

Alcohol Consumption

• Alcohol is the most common cause of elevated GGT, occurring in approximately 75% of habitual drinkers 3
• The American College of Gastroenterology recommends that patients with elevated GGT undergo evaluation for alcohol use disorder 3

Diagnostic Algorithm

• The initial step in evaluation is to confirm and characterize the elevation of ALP and GGT 1
• The American Association for the Study of Liver Diseases recommends that patients with elevated ALP and GGT undergo ultrasonography as the first-line imaging study 1, 2
• If ultrasonography is negative but ALP remains elevated, magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRCP) is recommended 1, 2

Laboratory Tests

• The American Society for Clinical Pathology recommends that patients with elevated ALP and GGT undergo measurement of bilirubin, ALT, and AST to evaluate for hepatocellular injury 1
• The calculation of the R value (ALT/ULN)/(ALP/ULN) can help classify the pattern of injury: cholestatic (R ≤2), mixed (R >2 and <5), or hepatocellular (R ≥5) 1

Special Considerations

• In patients with inflammatory bowel disease, PSC should be strongly suspected 1, 2
• In patients with abrupt elevations of liver tests, dominant stricture should be evaluated with MRCP or endoscopic retrograde cholangiopancreatography (ERCP) to detect cholangiocarcinoma 2

Monitoring in Advanced Liver Disease

• Patients with advanced liver disease should receive regular monitoring, including physical examination, laboratory tests, and nutritional evaluation every 6 months 4
• The American Association for the Study of Liver Diseases recommends that patients with advanced liver disease undergo regular monitoring for hepatocellular carcinoma and esophageal varices 4